[Combined use of lypopolysaccharides from actinomycetes and of antibiotics in the treatment of experimental sepsis in mice].
D000818:Animals; D004357:Drug Synergism; D004927:Escherichia coli Infections / Q000188:drug therapy* / Q000401:mortality; D008070:Lipopolysaccharides / Q000096:biosynthesis / Q000627:therapeutic use* / Q000633:toxicity; D051379:Mice; D011749:Pyrogens / Q000494:pharmacology; D011817:Rabbits; D013302:Streptomyces / Q000378:metabolism; D013307:Streptomycin / Q000627:therapeutic use*; D013752:Tetracycline / Q000627:therapeutic use*
D008070:Lipopolysaccharides; D011749:Pyrogens; D013752:Tetracycline; D013307:Streptomycin
Sovmestnoe primenenie lipopolisakharidov iz aktinomitsetov i antibiotikov dlia lecheniia éksperimental'nogo sepsisa u mysheĭ.